We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Metabolon partners with InnVentis to Study Chronic Inflammatory Diseases

News   Jan 06, 2017 | Metabolon

 
Metabolon partners with InnVentis to Study Chronic Inflammatory Diseases
 
 
 

RELATED ARTICLES

Studying Cells’ “Self-eating” Could Help Create New Dementia Drugs

News

A team from the University of Plymouth has shed light on the mechanisms behind cell "self-eating" and how it progresses. They hope that this information could be used to direct efforts towards new treatment for dementia.

READ MORE

Gene Therapy for Niemann-Pick Type a Diseases Moves Forward

News

Research shows that gene replacement therapy for Niemann-Pick type A disease is safe for use in nonhuman primates and has therapeutic effects in mice.

READ MORE

New Method to Synthesize and Screen Macrocyclic Compounds

News

Scientists at EPFL have found a way to generate libraries of more than 9,000 of macrocyclic molecules below 1 KDa, all with high structural diversity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE